Research ArticleArticle
Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors
Melissa A. Lerman, Jon M. Burnham, Peter Y. Chang, Ebenezer Daniel, C. Stephen Foster, Sean Hennessy, Douglas A. Jabs, Marshall M. Joffe, R. Oktay Kaçmaz, Grace A. Levy-Clarke, Monte D. Mills, Robert B. Nussenblatt, James T. Rosenbaum, Eric B. Suhler, Jennifer E. Thorne and John H. Kempen
The Journal of Rheumatology July 2013, jrheum.121180; DOI: https://doi.org/10.3899/jrheum.121180
Melissa A. Lerman
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Jon M. Burnham
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Peter Y. Chang
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Ebenezer Daniel
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
C. Stephen Foster
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Sean Hennessy
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Douglas A. Jabs
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Marshall M. Joffe
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
R. Oktay Kaçmaz
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Grace A. Levy-Clarke
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Monte D. Mills
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Robert B. Nussenblatt
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
James T. Rosenbaum
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Eric B. Suhler
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Jennifer E. Thorne
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
John H. Kempen
From the Division of Rheumatology, The Children’s Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Epidemiology and Biostatistics, Scheie Eye Institute/Department of Ophthalmology, and Perelman School of Medicine (SOM) at the University of Pennsylvania, Philadelphia; Massachusetts Eye Research and Surgery Institution, Ocular Immunology and Uveitis Foundation, Cambridge, Massachusetts; The New York Eye and Ear Infirmary, New York, New York; Harvard Medical School, Boston, Massachusetts; Departments of Medicine and Ophthalmology, Mount Sinai School of Medicine, New York, New York; Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, The Johns Hopkins University School of Medicine; Allergan Inc., Irvine, California; The Laboratory of Immunology, National Eye Institute, Bethesda, Maryland; Johnson & Johnson Vision Care, Jacksonville, Florida; Division of Ophthalmology, CHOP; Department of Ophthalmology, and the Division of Rheumatology, Department of Internal Medicine, Oregon Health Sciences University, and the Department of Ophthalmology, Portland Veteran’s Affairs Medical Center, Portland, Oregon, USA. Supported by a Rheumatology Research Foundation Scientist Development Award (Dr. Lerman); Autoimmunity Centers of Excellence, National Institute of Allergy and Infectious Diseases (Dr. Burnham); R01 EY014943 National Eye Institute (NEI), US National Institutes of Health (NIH; Drs. Daniel, Rosenbaum, Suhler, Thorne, and Kempen); grants AG025152 and AG035751 from the National Institute on Aging (Dr. Hennessy); cooperative agreements from the NEI and the NIH to the Mount Sinai School of Medicine (U10 EY08052), the Johns Hopkins University Bloomberg School of Public Health, (U10 EY08057), and the University of Wisconsin (U10 EY08067; Dr. Jabs); intramural funding from the NEI (Dr. Levy-Clarke, and previously, Dr. Nussenblatt); The US Department of Veterans Affairs (Dr. Suhler); research grants from Abbott, LuxBio Genentech, Bristol Myers Squibb, Novartis, EyeGate, and the RPB Sybil B. Harrington Special Scholars Award (Dr. Thorne); and Research to Prevent Blindness, and the Paul and Evanina Mackall Foundation (Dr. Kempen). M.A. Lerman, MD, PhD, MSCE, Instructor in Pediatrics, CHOP; J.M. Burnham, MD, MSCE, Assistant Professor of Pediatrics, Perelman SOM at the University of Pennsylvania; P.Y. Chang, MD, Resident in Ophthalmology, The New York Eye and Ear Infirmary; E. Daniel, MBBS, MPH, PhD, Instructor in Ophthalmology, Perelman SOM at the University of Pennsylvania; C.S. Foster, MD, Clinical Professor of Ophthalmology, Harvard Medical School; S. Hennessy, PharmD, PhD, Associate Professor of Epidemiology, Perelman SOM at the University of Pennsylvania; D.A. Jabs, MD, MBA, Professor of Ophthalmology and Medicine, Mount Sinai School of Medicine and Adjunct Professor of Epidemiology, Johns Hopkins University Bloomberg School of Public Health; M.M. Joffe, MD, MPH, PhD, Professor of Biostatistics, Perelman SOM at the University of Pennsylvania; R. Oktay Kaçmaz, MD, MPH, Medical Scientific Manager, Allergan Inc.; G.A. Levy-Clarke, MD, Project Director, Ophthalmology, Johnson & Johnson Vision Care; M.D. Mills, MD, Professor of Clinical Ophthalmology, Perelman SOM at the University of Pennsylvania; R.B. Nussenblatt, MD, MPH, Chief, Laboratory of Immunology, NEI; J.T. Rosenbaum, MD, Professor of Ophthalmology, Medicine and Cell Biology, OHSU; E.B. Suhler, MD, MPH, Associate Professor of Ophthalmology, OHSU; J.E. Thorne, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, The Wilmer Eye Institute, Johns Hopkins School of Medicine; J.H. Kempen, MD, PhD, Associate Professor of Ophthalmology and Epidemiology, Perelman SOM at the University of Pennsylvania. Address correspondence to Dr. M.A. Lerman, Division of Rheumatology, The Children’s Hospital of Philadelphia, Abramson Research Center, Suite 1102, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA. E-mail: lermanm@email.chop.edu. Accepted for publication May 9, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors
Melissa A. Lerman, Jon M. Burnham, Peter Y. Chang, Ebenezer Daniel, C. Stephen Foster, Sean Hennessy, Douglas A. Jabs, Marshall M. Joffe, R. Oktay Kaçmaz, Grace A. Levy-Clarke, Monte D. Mills, Robert B. Nussenblatt, James T. Rosenbaum, Eric B. Suhler, Jennifer E. Thorne, John H. Kempen
The Journal of Rheumatology Jul 2013, jrheum.121180; DOI: 10.3899/jrheum.121180
Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors
Melissa A. Lerman, Jon M. Burnham, Peter Y. Chang, Ebenezer Daniel, C. Stephen Foster, Sean Hennessy, Douglas A. Jabs, Marshall M. Joffe, R. Oktay Kaçmaz, Grace A. Levy-Clarke, Monte D. Mills, Robert B. Nussenblatt, James T. Rosenbaum, Eric B. Suhler, Jennifer E. Thorne, John H. Kempen
The Journal of Rheumatology Jul 2013, jrheum.121180; DOI: 10.3899/jrheum.121180